Skip to main content

Emtriva

NDC 61958-0602 · Gilead Sciences, Inc.

Generic nameEMTRICITABINE
Dosage formSOLUTION
RouteORAL
Active ingredient(s)EMTRICITABINE
Strength10 mg/mL
Pharmacologic classHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]
Marketing categoryNDA

Packages

61958-0602-1 — 1 BOTTLE, DISPENSING in 1 CARTON (61958-0602-1) / 170 mL in 1 BOTTLE, DISPENSING

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50090-6494 — Emtricitabine and Tenofovir Disoproxil Fumarate, 50090-7719 — Emtricitabine and tenofovir disoproxil fumarate, 50090-8028 — Emtricitabine and tenofovir disoproxil fumarate, 51407-112 — EMTRICITABINE and TENOFOVIR Disoproxil Fumarate, 59651-165 — Emtricitabine and Tenofovir Disoproxil Fumarate, 59651-166 — Emtricitabine and Tenofovir Disoproxil Fumarate, 59651-167 — Emtricitabine and Tenofovir Disoproxil Fumarate, 59676-800 — Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide, 60219-2095 — Emtricitabine and Tenofovir Disoproxil Fumarate, 61958-0601 — EMTRICITABINE, 61958-0701 — emtricitabine and tenofovir disoproxil fumarate, 61958-0703 — emtricitabine and tenofovir disoproxil fumarate, 61958-0704 — emtricitabine and tenofovir disoproxil fumarate, 61958-0705 — emtricitabine and tenofovir disoproxil fumarate, 61958-1101 — emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate, 61958-1201 — elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate, 61958-1901 — elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide, 61958-2002 — emtricitabine and tenofovir alafenamide, 61958-2005 — emtricitabine and tenofovir alafenamide, 61958-2101 — emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide, +52 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.